LXCHEMLaxmi Organic Industries Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Laxmi Organic Industries Limited, together with its subsidiaries, manufactures and trades acetyl intermediates and specialty chemicals in India and internationally. The company offers essential products, such as ethyl acetate, acetaldehyde, acetic anhydride, n-propyl acetate, n-butyl acetate, and other proprietary solvents; and specialty products, such as ketene and diketene derivatives, fluorospeciality intermediates, esters, amides, arylides, and various specialties chemicals. It serves various sectors, including pharmaceuticals/life sciences, packaging, agrochemicals, dyes, inks and paints, flame retardants and thermal fluids, electronics, fragrances and flavours, personal care, and electrical equipment, as well as coating, adhesives, sealants, and elastomers. The company also exports its products. The company was incorporated in 1989 and is based in Mumbai, India. Laxmi Organic Industries Limited is a subsidiary of Yellow Stone Trust.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Debt/Equity: 0.27
- • Promoter holding: 69.3%
- • RSI: 52
- • MACD: fresh bullish crossover
- • Price vs EMA21: above
- • 3-month return: +14.0%
- • Pullback to 21-EMA signal (setup quality 59%)
Bull case
- • Debt/Equity: 0.27
- • Promoter holding: 69.3%
- • RSI: 52
- • MACD: fresh bullish crossover
Bear case
- • Revenue growth: 3.6% YoY
- • Profit growth: -2.8% YoY
- • Trend strength (ADX): 15
- • Distance from 52-week high: 27.2% below high
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 3.6% YoY
- • Profit growth: -2.8% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹6.97). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.